I recently took a review course in general surgery to prepare for my board recertification examination in December and realized just how much the standard of care had changed in the decade since I last recertified. Then I learned that laetrile is still a thing. If there’s one thing that demonstrates the difference between alternative medicine and real medicine, it’s how no alternative medicine treatment ever goes away, no matter how often it’s shown not to work. Ever.
Search: “burzynski”
We found 426 results for your search.
“Right-to-try” laws claim to help terminally patients by allowing them access to experimental drugs before they are approved, when, in fact, their purpose is to undermine and weaken the FDA and such laws strip legal and regulatory protections from patients using such drugs. Now advocates are making a new push to pass right-to-try by embedding it in the very law that funds the FDA. They might succeed if they encounter no opposition from constituents.
Share this:
It’s been a bad week for the Gray Lady in the science department. Hot off the heels of hiring a climate science denier for its op-ed section, it’s published a credulous article that uncritically touts a book full of dubious alternative medicine testimonials.
Share this:
This week, the FDA sent warning letters to 14 companies making unsupported claims that their products can treat cancer. Given the new administration’s determination to deregulate almost everything, but especially the FDA, is this the last time in the foreseeable future that such a crackdown will occur?
Share this:
Ill-advised right-to-try bills are spreading like kudzu through state legislatures. Now federal legislators want to insert right-to-try language into the bill that funds FDA drug approval. Given the support of powerful Republicans for right-to-try, is it too late to stop this juggernaut and protect patients?
